US3893995A - Method for obtaining polyfructosans - Google Patents

Method for obtaining polyfructosans Download PDF

Info

Publication number
US3893995A
US3893995A US205293A US20529371A US3893995A US 3893995 A US3893995 A US 3893995A US 205293 A US205293 A US 205293A US 20529371 A US20529371 A US 20529371A US 3893995 A US3893995 A US 3893995A
Authority
US
United States
Prior art keywords
polyfructosan
extract
low alcohol
water
filtering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US205293A
Inventor
Ernst Nitsch
Siegried Muhlbock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laevosan GmbH and Co KG
Original Assignee
Laevosan GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laevosan GmbH and Co KG filed Critical Laevosan GmbH and Co KG
Application granted granted Critical
Publication of US3893995A publication Critical patent/US3893995A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0051Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives

Definitions

  • ABSTRACT A kidney function diagnostic agent comprising high water-soluble polyfructosans derived from the storage organs of monocotyledon plants.
  • inulin For this purpose, a known volume of inulin solution is administered parenterally and the elimination of the inulin is followed up with a periodic concentration determination in the blood and the urine.
  • the prerequisite for this use is the property of inulin to be neither stored, nor chemically altered in the body.
  • inulin has so far proved to be excellent for this task as a standard substance.
  • the chief disadvantage in the use of inulin resides in the fact that it is difficult to dissolve in cold water.
  • the normally employed percent solution crystallizes at cold temperatures, and is accompanied by the formation of a crusty precipitate. Before it can be given to a patient, this precipitate must once again be dissolved through heat.
  • kidney diagnostic agents themselves longknown, comprising the watersoluble polyfructosans from the storage organs of certain monocotyledon plants, and especially, from the families of the Liliaceae and the Gramineae.
  • the object of this invention is to provide a kidney function diagnostic agent with a polyfructosan content, which is characterized by the fact that it contains water-soluble polyfructosans easily soluble in water from the storage organs of monocotyledon plants, and especially from the families of the Lilicaeae and Gramineae.
  • a further object of this invention is to provide a method for the production of polyfructosans for use as a kidney function diagnostic agent, which comprises extracting the particular drugs with low alcohols or with acetone having a water content of -40 percent.
  • the extract is preferably brought to a pH of 9 with calcium hydroxide, filtered, and concentrated under reduced pressure, into a thick syrup, whereupon the thickened extract, after addition of about half its weight in a low alcohol (preferably methanol) is aciditied with a strong acid (preferably hydrochloric acid) to a pH of between 1 and 3.
  • the polyfructosan is then precipitated with a 2 to 8 fold weight of a low alcohol (preferably methanol) or with acetone, and the precipitate thus obtained is converted into a powdery crystalline form through repeated kneading with a water-free precipitation agent.
  • a low alcohol preferably methanol
  • acetone preferably acetone
  • the solution of the polyfructosan thus obtained can be completely desalted via ion-exchange, treated with active carbon (active charcoal), filtered, and then either filled, after removal of the organic solvent residues by means of distillation, directly into ampoules, or optionally it can be dried, after concentration into a syrup consistency, in a vacuum, to a thin layer.
  • the coarsely comminuted plant material is repeatedly extracted with aqueous alcohols or acetone (preferably methanol, ethanol, or isopropanol) or with acetone having 80-40 percent water by means of percolation, if necessary, at increased temperatures.
  • aqueous alcohols or acetone preferably methanol, ethanol, or isopropanol
  • acetone having 80-40 percent water by means of percolation, if necessary, at increased temperatures.
  • the function of the organic solvent is (1) to prevent degradation by microorganisms, (2) to suppress the effect of the polyfructosan-decomposing ferments, and (3) to prevent the dissolution of interfering pectin and shiny substances.
  • the extracts thus obtained are alkalized to a pH value of 9 with milk of lime (calcium hydroxide), filtered and the resultant filtrate is evaporated in a vacuum to produce a syrup of about 70-80 percent dry substance content.
  • the precipitate which consists of a white, viscous mass, is separated from the supernatant liquid and is thoroughly kneaded several times with small portions of solvent, thereby forming a fine-grained crystalline product which finally is liberated from the adhering liquid by centrifuge or suction filter.
  • the substance thus obtained is already very pure but, for parenteral application, it must be dissolve again in water and further purified by'means of ion exchange and filtration of the desalted solution with active carbon.
  • the solution thus obtained can either be filled directly into ampoules after removal of the solvent residues through distillation and adjustment' of the EXAMPLE 1 Productionof Polyfructosan (Sinistrin) From the Onion Bulbs of the Composite Urginea Maritima 100 Kg of commercially available dried red sea onion were coarsely ground in a knife-mill with a screen insert having a 4-mm perforation diameter, they are premoistened with 200 Kg of a percent watery metha'v nol solution, and percolated, after standing, for 24 hours with the same solvent at room ter'nperaturehav-v ing a runoff speed of about 4 Kg per hour. A total of 300 Kg of extract were obtained.
  • the extract was brought to a pH of 9 with a suspension of 250 g of calcium hydroxide in a little water,the precipitate was filtered off, and the liquid was evaporated, in a vacuum, to a thick syrup. About 75 Kg of syrup containing 80 percent of solid substance was obtained. Accompanied by forceful stirring, 30 Kg of methanol wereintroduced into a thin jet and the almost clear solution, was cooled down to 15C. Accompanied by furtherforceful stirring, a cooled off mixture consisting of 3 liters of concentrated hydrochloric acid and 8 Kg of methanol was added. As a result, Sinistrin was precipitated as a viscous, nacreously-brilliant, yellowish-white mass. The solution, which was clear yellow after standing briefly, was poured off as completely as possible. It contained .salts, fructose and low-molecular oligosaccharides.
  • the Sinistrin precipitate about 40 Kg, was forcefully kneaded three times with 40 Kg of methanol, each 4 time, in a kneading machine.
  • the supernatant methanol was poured off in each case and was combined with the one obtained during the firstprecipitation, whereby the entire mass was converted into a fine-grained cyrstallin'e suspension. This was contrifuged on a centrifuge and the substance isolated (about 35 Kg).was dissolved in 70 Kg of water.

Abstract

A kidney function diagnostic agent comprising high water-soluble polyfructosans derived from the storage organs of monocotyledon plants.

Description

United States Patent Nitsch et a1.
July 8, 1975 METHOD FOR OBTAINING POLYFRUCTOSANS Inventors: Ernst Nitsch; Siegried Muhlbock, both of Linz, Austria Assignee: Laevosan-Gesellschaft mlbH & Co.
KG, Linz, Austria Filed: Dec. 6, 1971 App]. No.: 205,293
Foreign Application Priority Data References Cited UNITED STATES PATENTS 5/1958 I-Iill 260/209 R OTHER PUBLICATIONS Schlubach et al., Chem. Abst, Vol. 51, 1957, pp. 16310g16311b.
Schlubach et al., Chem. Abst., Vol. 52, 1958, p. 3698 d.
Schlubach et al., Chem. Abst, Vol. 52, 1958, pp. 19,963 i l9,965 0.
Primary Examiner-Johnnie R. Brown Attorney, Agent, or Firm-Sughrue, Rothwell, Mion, Zinn & Macpeak [57] ABSTRACT A kidney function diagnostic agent comprising high water-soluble polyfructosans derived from the storage organs of monocotyledon plants.
7 Claims, N0 Drawings METHOD FOR OBTAINING POLYFRUCTOSANS BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a new kidney diagnostic agent which, when administered parenterally, is neither degradated nor altered in the body and which is able to be eliminated through the kidneys. On the basis of the elimination speed and the quantity eliminated, one can draw conclusions as to the function of the kidney.
2. Description of the Prior Art About 35 years ago, inulin, a polyfructosan from the storage organs of certain types of composites (for example, Inula helenium, Helianthus tuberosus, Cichorium intybus), were introduced into kidney diagnosis as a clearance substance for the determination of the size of the glomerulum filtrate; see Richards A. N., Westfall B. B. and Pott A. A. Proc. Exper. Biol. (N.Y.), 32, 73 (1934); Shannon .1. A. and Smith H. W., Clin. Invest. 20, 169 (1935). For this purpose, a known volume of inulin solution is administered parenterally and the elimination of the inulin is followed up with a periodic concentration determination in the blood and the urine. The prerequisite for this use is the property of inulin to be neither stored, nor chemically altered in the body. In spite of certain practical disadvantages, inulin has so far proved to be excellent for this task as a standard substance. The chief disadvantage in the use of inulin resides in the fact that it is difficult to dissolve in cold water. The normally employed percent solution crystallizes at cold temperatures, and is accompanied by the formation of a crusty precipitate. Before it can be given to a patient, this precipitate must once again be dissolved through heat. At this point there is a danger that the inulin could be hydrolyzed into low molecular fractions and fructose, which in contrast to inulin, are broken down by the body; on the other hand, after injection of insufficiently dissolved preparations blockage of the thinner blood vessels of the body may occur which could precipitate serious physiological complications.
SUMMARY OF THE INVENTION In accordance with this invention, there is now proposed, new kidney diagnostic agents, themselves longknown, comprising the watersoluble polyfructosans from the storage organs of certain monocotyledon plants, and especially, from the families of the Liliaceae and the Gramineae.
Thus, the object of this invention is to provide a kidney function diagnostic agent with a polyfructosan content, which is characterized by the fact that it contains water-soluble polyfructosans easily soluble in water from the storage organs of monocotyledon plants, and especially from the families of the Lilicaeae and Gramineae.
DETAILED DESCRIPTION OF THE INVENTION For reasons of economy, one takes into prime consideration the use of Sinistrin, a polyfructosan from the sea onion (Urginea maritima) see Schmiedeberg O., l-loppe Seylers Z. Physio]. Ehem (Journal of Physiological Chemistry), 3, 1 12 (1879) and Schluback H. H. and Florshein W., Ber. dtsch. (Reports of the German Chemical Society) 62, (1929), and the polyfructosan from garlic (Allium sativum), as well as Graminin and Triticin, see Klein 6., Handbuch der Pflanzenanalyse (Handbook of Plant Analysis), Spring 1932, 1st part, pages 866873, and Paech K. and Tracey M. V., Moderne Methoden der Pflanzenanalyse (Modern Methods of Plant Analysis) Springer 1955, 2nd Volume, pages 184-196.
All of these polyfructosans are characterized in that l they are easily water-soluble, (2) they are easily hydrolyzed by acids, (3) their average molecular weight is about 3,000, corresponding to about 18 monosaccharide units, and (4) their fructose residues are primarily B-1,2-bound, see Schlubach H. H., Sing. 0. K., Liebigs Ann. (Liebigs Yearbook) 544, 1 11 (1940). Furthermore, these compounds prove to be completely non-toxic when tested clinically and pharmacologically.
For the production of the above-mentioned watersoluble polyfructosans, the methods described in the literature to date leave much to be desired (Schmiedeberg 0., I-Ioppe Seylers Z. Physio]. Chemistry 3, 112 (1879) and Klein G. Handbuch der Pflanzenanalyse, Springer 1932, 1st part, pages 866-873.) Basically, they reside in the preparation of a watery extract from which a part of the ballast substance is removed through precipitation with vinegar of lead. This is followed by subsequent removal of the lead and the polyfructosans are then precipitated as lime or barite compounds by the addition of milk of lime or baryta water. After filtering by suction and washing, they are broken down into carbonic or oxalic acid, after which the polyfructosan solution thus purified is concentrated into a syrup and precipitated with alcohol. Since the precipitation very stubbornly produces monosaccharides and other impurities, numerous re-precipitations are normally required in order to attain a sufficient degree of purity.
A further object of this invention is to provide a method for the production of polyfructosans for use as a kidney function diagnostic agent, which comprises extracting the particular drugs with low alcohols or with acetone having a water content of -40 percent. The extract is preferably brought to a pH of 9 with calcium hydroxide, filtered, and concentrated under reduced pressure, into a thick syrup, whereupon the thickened extract, after addition of about half its weight in a low alcohol (preferably methanol) is aciditied with a strong acid (preferably hydrochloric acid) to a pH of between 1 and 3. The polyfructosan is then precipitated with a 2 to 8 fold weight of a low alcohol (preferably methanol) or with acetone, and the precipitate thus obtained is converted into a powdery crystalline form through repeated kneading with a water-free precipitation agent. If desired, the solution of the polyfructosan thus obtained can be completely desalted via ion-exchange, treated with active carbon (active charcoal), filtered, and then either filled, after removal of the organic solvent residues by means of distillation, directly into ampoules, or optionally it can be dried, after concentration into a syrup consistency, in a vacuum, to a thin layer.
The method just described is best carried out as follows:
The coarsely comminuted plant material is repeatedly extracted with aqueous alcohols or acetone (preferably methanol, ethanol, or isopropanol) or with acetone having 80-40 percent water by means of percolation, if necessary, at increased temperatures. The function of the organic solvent is (1) to prevent degradation by microorganisms, (2) to suppress the effect of the polyfructosan-decomposing ferments, and (3) to prevent the dissolution of interfering pectin and shiny substances. The extracts thus obtained are alkalized to a pH value of 9 with milk of lime (calcium hydroxide), filtered and the resultant filtrate is evaporated in a vacuum to produce a syrup of about 70-80 percent dry substance content. After cooling, it is, portion by portion, mixed with so much of a low alcohol illustrated above (preferably methanol) or with acetone until no remaining precipitate develops; concentrated hydrochloric acid is then added to obtain a pH of l to, 3 'and preferably 2.5. Next, we add a sufficient amount of solvent (same as above) to complete precipitation. 1n adding the acid, we assure that a large part of the existing salts and dyes, which otherwise would also be precipitated, remain in solution. The precipitate, which consists of a white, viscous mass, is separated from the supernatant liquid and is thoroughly kneaded several times with small portions of solvent, thereby forming a fine-grained crystalline product which finally is liberated from the adhering liquid by centrifuge or suction filter. The substance thus obtained is already very pure but, for parenteral application, it must be dissolve again in water and further purified by'means of ion exchange and filtration of the desalted solution with active carbon. Finally, the solution thus obtained can either be filled directly into ampoules after removal of the solvent residues through distillation and adjustment' of the EXAMPLE 1 Productionof Polyfructosan (Sinistrin) From the Onion Bulbs of the Composite Urginea Maritima 100 Kg of commercially available dried red sea onion were coarsely ground in a knife-mill with a screen insert having a 4-mm perforation diameter, they are premoistened with 200 Kg of a percent watery metha'v nol solution, and percolated, after standing, for 24 hours with the same solvent at room ter'nperaturehav-v ing a runoff speed of about 4 Kg per hour. A total of 300 Kg of extract were obtained. The extract was brought to a pH of 9 with a suspension of 250 g of calcium hydroxide in a little water,the precipitate was filtered off, and the liquid was evaporated, in a vacuum, to a thick syrup. About 75 Kg of syrup containing 80 percent of solid substance was obtained. Accompanied by forceful stirring, 30 Kg of methanol wereintroduced into a thin jet and the almost clear solution, was cooled down to 15C. Accompanied by furtherforceful stirring, a cooled off mixture consisting of 3 liters of concentrated hydrochloric acid and 8 Kg of methanol was added. As a result, Sinistrin was precipitated as a viscous, nacreously-brilliant, yellowish-white mass. The solution, which was clear yellow after standing briefly, was poured off as completely as possible. It contained .salts, fructose and low-molecular oligosaccharides.
Methanol can then be recovered from it by distillation and rectification. I
' The Sinistrin precipitate, about 40 Kg, was forcefully kneaded three times with 40 Kg of methanol, each 4 time, in a kneading machine. The supernatant methanol was poured off in each case and was combined with the one obtained during the firstprecipitation, whereby the entire mass was converted into a fine-grained cyrstallin'e suspension. This was contrifuged on a centrifuge and the substance isolated (about 35 Kg).was dissolved in 70 Kg of water. The solution was then stirred with 3 Kg of active carbon, filtered, and it was then moved at about 15 liters per hour over a mixing bed consisting of 5 liters of a slightly acid cation exchanger in the PH form and 10 liters of a strongly basic anion exchanger in the 01-1 form. The Rein-Sinistrin solution thus obtained was concentrated into'a thick syrup (in tary power: i I
[a] =39.2 (c 10, H O). Yield: 31.5 Kg.
' EXAMPLE 2 Production of Polyfructosan From Garlic (Allium I Sativum) Stalks, roots, and external dry skins were stripped coarsely from 100 Kg of garlic and the rest was run through a meat grinder. The pap was immediatelyforcefully mixed with 30 Kg of isopropanol and was percolated, after standing about 12 hours, with a 30% watery isopropanol solution, at a runoff speed of about 2.5 Kg per hour. A total of 200 Kg of extract was obtained. Further processing was accomplished exactly in the manner of Example 1. Yield: 10.5 Kg. Optical rotary power:
[a] 40.5 (c= 10, B 0). The other properties exhibited were as described in Example 1.
Although the present invention has been adequately described in the foregoing specification and'examples included therein, it is readily apparent that various changes and modifications can be made without departing from the spirit and scope of the invention.
c. filtering and concentrating said extract into a thick syrup under reduced pressure,
d. adding to said extract, in an amount equal to about half of said extracts weight, a low alcohol,
e. acidifying said extract with a strong acid, to obtain .a pH of between 1 and 3,
f. subsequently precipitatingthe polyfructosan with a member selected from the goup consisting of a low alcohol and acetone, in an amount of 2 to 8 times the weight of said extract, and
g. converting the precipitate thus formed into a powdery crystalline state by repeatedly kneading the same with a water-free precipitation agent.
2. The process of claim ll, further comprising the step of desalting the polyfructosan thus obtained by means of ion exchange.
3. The process of claim 2, further comprising the step of filtering the thus desalted polyfructosan with active carbon.
4. The process of claim 3, further comprising the step of removing the organic solvent residues remaining through distillation, or drying said polyfructosan after concentration, into a syrup consistency in a vacuum at a maximum temperature of 80C.
5. The process of claim 1, wherein said low alcohol vacuum at a maximum temperature of C.

Claims (7)

1. A METHOD FOR OBTAINING THE HIGLY WATER-SOLUBLE POLYFRUCTOSANS FROM THE STORAGE ORGANS OF MONOCOTYLEDON PLANTS, WHICH COMPRISES, A. EXTRACTING SAID POLYFRUCTOSAN WITH A MEMBER SELECTED FROM THE GROUP CONSISTING OF A LOW ALCOHOL AND ACETONE HAVING A WATER CONTENT OF FROM 80-40 PERCENT, B. BRINGING SAID EXTRACT TO A PH OF ABOUT 9 WITH CALCIUM HYDROXIDE, C. FILTERING AND CONCENTRATING SAID EXTRACT INTO A THICK SYRUP UNDER REDUCED PRESSURE, D. ADDING TO SAID EXTRACT, IN AN AMOUNT EQUAL TO ABOUT HALF OF SAID EXTRACT''S WEIGHT, A LOW ALCOHOL, E. ACIDIFYING SAID EXTRACT WITH A STRONG ACID, TO OBTAIN A PH OF BETWEEN 1 TO 3, F. SUBSEQUENTLY PRECIPITATING THE POLYFRUCTOSAN WITH A MEMBER SELECTED FROM THE GROUP CONSISTING OF A LOW ALCOHOL AND ACETONE, IN AN AMOUNT OF 2 TO 8 TIMES THE WEIGHT OF SAID EXTRACT, AND G. CONVERTING THE PRECIPITATE THUS FORMED INTO A POWDERY CRYSTALLINE STATE BY REPEATEDLY KNEADING THE SAME WITH A WATER-FREE PRECIPITATION AGENT.
2. The process of claim 1, further comprising the step of desalting the polyfructosan thus obtained by means of ion exchange.
3. The process of claim 2, further comprising the step of filtering the thus desalted polyfructosan with active carbon.
4. The process of claim 3, further comprising the step of removing the organic solvent residues remaining through distillation, or drying said polyfructosan after concentration, into a syrup consistency in a vacuum at a maximum temperature of 80*C.
5. The process of claim 1, wherein said low alcohol is a member selected from the group consisting of methanol, ethanol and isopropanol.
6. The process of claim 1, wherein said strong acid is HCl.
7. A method for purifying the polyfructosan obtained in claim 1, which comprises: a. desalting the polyfructosan thus obtained by means of ion exchange, b. filtering the thus obtained desalted polyfructosan with active carbon, and c. removing the organic solvent resiDues remaining through distillation, or drying said polyfructosan after concentration, into a syrup consistency in a vacuum at a maximum temperature of 80*C.
US205293A 1970-12-09 1971-12-06 Method for obtaining polyfructosans Expired - Lifetime US3893995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1105570A AT304769B (en) 1970-12-09 1970-12-09 Kidney function diagnostic and process for its production

Publications (1)

Publication Number Publication Date
US3893995A true US3893995A (en) 1975-07-08

Family

ID=3626494

Family Applications (1)

Application Number Title Priority Date Filing Date
US205293A Expired - Lifetime US3893995A (en) 1970-12-09 1971-12-06 Method for obtaining polyfructosans

Country Status (13)

Country Link
US (1) US3893995A (en)
JP (1) JPS5420568B1 (en)
AT (1) AT304769B (en)
CA (1) CA973173A (en)
CH (1) CH573751A5 (en)
CS (1) CS161145B2 (en)
DE (1) DE2158467C3 (en)
DK (1) DK132928C (en)
FR (1) FR2117917B1 (en)
GB (2) GB1369849A (en)
SE (1) SE419404B (en)
SU (1) SU472509A3 (en)
YU (1) YU307471A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561226A (en) * 1991-01-23 1996-10-01 Laevosan Gesellschaft Mbh Process for the production of a pyrogen-free fructan which is readily water-soluble

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834694A (en) * 1955-10-07 1958-05-13 Hill Robert Fructose polymers and method of preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834694A (en) * 1955-10-07 1958-05-13 Hill Robert Fructose polymers and method of preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561226A (en) * 1991-01-23 1996-10-01 Laevosan Gesellschaft Mbh Process for the production of a pyrogen-free fructan which is readily water-soluble

Also Published As

Publication number Publication date
CH573751A5 (en) 1976-03-31
YU307471A (en) 1982-06-18
SU472509A3 (en) 1975-05-30
DE2158467C3 (en) 1982-04-08
GB1369850A (en) 1974-10-09
FR2117917A1 (en) 1972-07-28
FR2117917B1 (en) 1975-08-01
AT304769B (en) 1973-01-25
CA973173A (en) 1975-08-19
DK132928B (en) 1976-03-01
JPS5420568B1 (en) 1979-07-24
SE419404B (en) 1981-08-03
GB1369849A (en) 1974-10-09
DE2158467A1 (en) 1972-06-15
DE2158467B2 (en) 1981-04-23
DK132928C (en) 1976-07-26
CS161145B2 (en) 1975-05-04

Similar Documents

Publication Publication Date Title
US4511559A (en) Biologically active polysaccharide concentrates and process for production of preparates containing such substances
Hibbert et al. Studies on reactions relating to carbohydrates and polysaccharides. XXXIV. The constitution of levan and its relation to inulin
US3893995A (en) Method for obtaining polyfructosans
Hassid The isolation of a sodium sulfuric acid ester of galactan from Irideae Laminarioides (Rhodophyceae)
JPH06506236A (en) Renal diagnostic agent that can be applied parenterally
Dodds et al. Some Observations on the Properties and Preparation of Insulin, with Special Reference to the Picrate-Acetone Method of Preparation
Gutmann et al. The metabolism of 2-aminofluorene in the rat
Schryver et al. The Pectic Substances of Plants: Preliminary communication
US3110711A (en) Process of producing two escin isomers from horse chestnut extracts, and products
Haas et al. The metabolism of calcareous algae. I
CA1203800A (en) Process for obtaining laxative compounds from senna drug
Kendall The thyroid hormone
Conrad The decarboxylation of d-galacturonic acid with special reference to the hypothetical formation of l-arabinose
JP3121850B2 (en) Method for isolating acid secretion inhibitor
Gough The specific carbohydrate of the tubercle bacillus
US1725652A (en) Process of extracting the cardio-active substance of bulbous scillae
PL79425B1 (en)
EP0000439B1 (en) Method of purifying an insulin-containing aqueous ethanolic raw extract from pancreas glands
Hopkins et al. Glucuronic acid, a constituent of the gum of root nodule bacteria
MIYAKE CHEMICAL STUDIES OF CORN POLLEN II. Carbohydrates and Organic Bases
IL34178A (en) Extracts from plants of the genus hypoxis and medicinal preparations containing them
KR840001510B1 (en) Process for preparing extract from plant of genus epimedium s.p.
Brandwijk THE CHEMISTRY OF THE ROOT OF XYSMALOBIUM UNDULATUM, R. Br: (South African National Herbarium No. 3299.)
Sharpey-Schäfer Text-book of Physiology
US2022617A (en) Process of obtaining thevetin from the seeds of thevetia nerhfolia juss. or exile nut